aquadvantage salmon genetically engineered ge fish ge atlantic salmon developed aquabounty technologies typical growth hormoneregulating gene atlantic salmon replaced growth hormoneregulating gene pacific chinook salmon promoter sequence ocean pout gene enables gm salmon grow yearround instead spring ge salmon commercially competitive alternative wildcaught salmon fish farming unmodified salmon purpose modifications increase speed fish grows without affecting ultimate size qualities fishfarmed atlantic salmon growth rates already improved wild fish result traditional selective breeding practices however gm fish able grow even faster grow market size months rather three aquadvantage salmon first genetically engineered animals approved human consumption united states approval subject much aquadvantage salmon developed addition single copy construct consists promoter sequence ocean pout directing production growth hormone protein using coding sequence chinook vii continuous expression transgene allows fish grow yearround instead spring stability new dna construct tested revealing additional mutational effects insertion two desired gm fish backcrossed twogeneration breeding protocol starts generating hybrid offspring two inbred strains one carrying mutation interest wildtype atlantic salmon genetically modified gene sequence identical second fourth generations indicating insertion wild atlantic salmon salmo salar two sets chromosomes raised aquaadvantage salmon three sets ie triploid induction triploidy treatment eggs renders fish sterile reducing risk interbreeding wildtype fish genetically modified fish introduced three main concerns regarding approval ge salmon consumption fish could harmful could unintended consequences gene alteration nonsterile fish could escape intermingle wild population risks assessments conducted determine health safety technology number preventatives implemented prevent release fish fish one eight food types food drug administration fda required law treat special care regard part regulatory process fda required data whether changes occur kinds levels fish allergens parvalbumin aquadvantage fda upheld people allergies atlantic salmon likely allergic aquadvantage salmon due similar species properties genetically aquadvantage salmon safe eat nonge salmon significant food safety hazards associated human health concerns arise due increased hormone content edible tissue transgenic aquadvantage salmon showed statistical difference concentration insulinlike growth factor yet amount found aquadvantage salmon similar lower amounts found common animal products organic cow concern genetic engineering another gene one intended may also accidentally genome sequence aquadvantage salmon analyzed offtarget effects changes genes critics raised concerns potential environmental impacts fish reached rivers oceans modeled invasion scenarios seminatural environments suggest gm salmon would outcompete wildtype address concerns biological containment fda requires aquabounty take precautionary measures ensure transgenic fish mix wild population aquaculture uses conventionally bred salmon mostly atlantic salmon cultivates fish net pens north america occurs mostly coastal waters washington british columbia maine however application fda approval aquadvantage salmon specified landbased tank cultivation ocean aquabounty also altered fish female sterile male fish created eggproducing service kept secure landbased facilities canada eggs shipped landbased aquaculture facility indiana order make fish sterile aquadvantage salmon eggs treated pressure create batches fish eggs three copies chromosome triploid rather two copies diploid batch contains percent diploid fish destroyed diploid fish capable september fda advisory panel indicated fish highly unlikely cause significant effects environment safe food conventional atlantic october lawmakers asked fda reject application groups requested fish carry label identifying transgenic concerns included alleged flaws sterilization isolation excessive antibiotic december fda published draft environmental assessment aquadvantage fda also published preliminary finding significant period public comment elapse fda reviewed aquadvantage salmon arbitrarily extended may fda approved aquabounty technologies application sell aquadvantage salmon us consumers november however rider spending bill signed law december president obama bans import fda mandates labels genetically modified decision marks first time genetically modified animal approved enter united states food supply decision came nearly twenty years company first submitted data fda raised ten generations announcement released fda states aquadvantage salmon safe eat nongenetically engineered ge atlantic salmon also one month later language introduced proposed federal spending bill requiring consumer notification fish genetically october aquaadvantage salmon sold us import salmon eggs canada raised aquaadvantage fish farm indiana prohibited however march import alert issued previously fda deactivated aquadvantage salmon may sold us salmon eggs may imported indiana november united states district court northern district california granted motion force fda reconsider approval aquadvantage holding fda failed follow procedures ignoring environmental consequences sales us started may november environment canada approved product salmon egg production commercial purposes may canadian food inspection agency approved sale gm july aquabounty technologies said sold tons aquaadvantage salmon fillets customers canadacitation needed httpsenwikipediaorgwikiaquadvantagesalmon